EGFR and central nervous system neoplasm: In additional trials, BrainChild-02 (NCT03638167) delivers EGFR-specific CAR T cells to pediatric CNS tumor patients, and BrainChild-03 (NCT04185038), delivered CD276-specifc CAR T cells to pediatric patients with CNS tumors, including DIPG.